Pediatric Pharmacokinetics Human Development and Drug Disposition

被引:35
|
作者
Funk, Ryan S. [1 ]
Brown, Jacob T. [1 ]
Abdel-Rahman, Susan M. [1 ,2 ]
机构
[1] Childrens Mercy Hosp & Clin, Div Clin Pharmacol & Med Toxicol, Kansas City, MO 64108 USA
[2] Univ Missouri, Dept Pediat, Sch Med, Kansas City, MO 64108 USA
关键词
Pediatric; Pharmacokinetic; Development; Absorption; Distribution; Metabolism; Excretion; Transport; SINGLE-DOSE PHARMACOKINETICS; PLASMA-PROTEIN BINDING; AGE-RELATED-CHANGES; TISSUE DISTRIBUTION; HUMAN LIVER; POPULATION PHARMACOKINETICS; INTRAVENOUS OMEPRAZOLE; HEALTHY-VOLUNTEERS; PRETERM INFANTS; SMALL-INTESTINE;
D O I
10.1016/j.pcl.2012.07.003
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Human development is described by the various anatomic and physiologic changes that occur as the single-celled zygote matures into an adult human being. Concomitant with bodily maturation are changes in the complex interactions between pharmacologic agents and the biologic matrix that is the human body. Profound changes in the manner by which drugs traverse the body during development can have significant implications in drug efficacy and toxicity. Although not a replacement for well-conducted, pediatric, pharmacokinetic studies, an understanding of developmental biology and the mechanisms for drug disposition invariably assists the pediatric clinician with the judicious use of medications in children.
引用
收藏
页码:1001 / +
页数:17
相关论文
共 50 条
  • [31] HUMAN PHARMACOKINETICS AND DISPOSITION OF SARMOXICILLIN, A LIPOPHILIC AMOXICILLIN PRODRUG
    SMYTH, RD
    PFEFFER, M
    VANHARKEN, DR
    COHEN, A
    HOTTENDORF, GH
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1981, 19 (06) : 1004 - 1012
  • [32] PHARMACOKINETICS AND DISPOSITION OF [14C]-LURASIDONE IN HUMAN
    Chiu, Y.
    Gu, K.
    Poola, N.
    Sarubbi, D.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 : S51 - S51
  • [33] Application of allometric principles for the prediction of pharmacokinetics in human and veterinary drug development
    Mahmood, Iftekhar
    ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (11) : 1177 - 1192
  • [34] A CAL system for teaching elementary drug disposition and pharmacokinetics: Version 2
    McEwen, G
    Ogg, GD
    Stevenson, IH
    BRITISH JOURNAL OF PHARMACOLOGY, 1996, 119 : P373 - P373
  • [35] DISPOSITION AND PHARMACOKINETICS IN RATS OF MCN-5707, A POTENTIAL ANTIDEPRESSANT DRUG
    NG, KT
    HOLLAND, ML
    HILLS, JF
    UETZ, JA
    FEDERATION PROCEEDINGS, 1986, 45 (03) : 206 - 206
  • [37] Pediatric Obesity: Pharmacokinetics and Implications for Drug Dosing
    Kendrick, Jennifer G.
    Carr, Roxane R.
    Ensom, Mary H. H.
    CLINICAL THERAPEUTICS, 2015, 37 (09) : 1897 - 1923
  • [38] Imaging drug pharmacokinetics in oncology drug development
    Price, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S158 - S158
  • [39] DEVELOPMENT OF A PRIMARY HUMAN HEPATOCYTE SPHEROID CULTURE MODEL FOR DRUG METABOLISM AND DISPOSITION STUDIES
    Kanebratt, Kajsa P.
    Janefeldt, Annika
    Peric, Alexandra
    Jonsson, Julia
    Johansson, Linnea
    Hilgendorf, Constanze
    Andersson, Tommy B.
    DRUG METABOLISM AND PHARMACOKINETICS, 2018, 33 (01) : S69 - S69
  • [40] The development of models for the evaluation of pulmonary drug disposition
    Liu, Xin
    Jin, Lu
    Upham, John W.
    Roberts, Michael S.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2013, 9 (04) : 487 - 505